c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseasesDaniela A.Gutiérrez, América Chandía-Cristi, María JoséYá?ez, Silvana Zanlungo, Alejandra R.álvarez237-243
The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhageQi Tian, Sheng Liu, Shou-Meng Han, Wei Zhang, Xian-Yao Qin, Jun-Hui Chen, Cheng-Li Liu, Yu-Jia Guo, Ming-Chang Li244-252
Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapyMaría Jose Bellini, Florencia Labombarda253-257
Functions and mechanisms of cytosolic phospholipase A2 in central nervous system traumaHao-Jie Zhang, Yi-Tuo Chen, Xin-Li Hu, Wan-Ta Cai, Xiang-Yang Wang, Wen-Fei Ni, Kai-Liang Zhou258-266
Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?Victoria Sofia Berenice Wies Mancini, Anabella Ayelen Di Pietro, Laura Andrea Pasquini267-272
Cre-recombinase systems for induction of neuron-specific knockout models: a guide for biomedical researchersTetiana Shcholok, Eftekhar Eftekharpour273-279
Prenatal programing of motivated behaviors: can innate immunity prime behavior?Larisa Montalvo-Martínez, Gabriela Cruz-Carrillo, Roger Maldonado-Ruiz, Luis A.Trujillo-Villarreal, Eduardo A.Garza-Villarreal, Alberto Camacho-Morales280-283
Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative reviewFioravante Capone, Mariagrazia Rossi, Alessandro Cruciani, Francesco Motolese, Fabio Pilato, Vincenzo Di Lazzaro284-288
Simulating traumatic brain injury in vitro: developing high throughput models to test biomaterial based therapiesRaja Haseeb Basit, Jessica Wiseman, Farhana Chowdhury, Divya Maitreyi Chari289-292
Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson's diseaseBaptiste Texier, Morgane Prime, Djamaa Atamena, Pascale Belenguer, Marion Szelechowski293-298
